Treatment of laryngopharyngeal reflux: A comparison between domperidone plus omeprazole and omeprazole alone

Journal of the Medical Association of Thailand

Volumn 95, Issue 1, 2012, Pages 73-80

  Hunchaisri, Niran ^a  

^a SRINAKHARINWIROT UNIVERSITY   (Thailand)

Author keywords

Domperidone; Laryngopharyngeal reflux; Omeprazole; Prokinetic; Proton pump inhibitor

Indexed keywords

DOMPERIDONE; OMEPRAZOLE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; LARYNGOPHARYNGEAL REFLUX; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REFLUX SYMPTOM INDEX; SCORING SYSTEM; SEX DIFFERENCE;

ANTI-ULCER AGENTS; CHI-SQUARE DISTRIBUTION; DOMPERIDONE; DOPAMINE ANTAGONISTS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LARYNGOPHARYNGEAL REFLUX; MALE; MIDDLE AGED; OMEPRAZOLE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84856940056     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991; 101: 1-78.
2. Bain WM, Harrington JW, Thomas LE, Schaefer SD. Head and neck manifestations of gastroesophageal reflux. Laryngoscope 1983; 93: 175-9.
3. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825-31.
4. Belafsky PC, Postma GN, Koufman JA. Validity and reliability of the reflux symptom index (RSI). J Voice 2002; 16: 274-7.
5. Kawamura O, Aslam M, Rittmann T, Hofmann C, Shaker R. Physical and pH properties of gastroesophagopharyngeal refluxate: a 24-hour simultaneous ambulatory impedance and pH monitoring study. Am J Gastroenterol 2004; 99: 1000-10.
6. Koufman JA, Aviv JE, Casiano RR, Shaw GY. Laryngopharyngeal reflux: position statement of the committee on speech, voice, and swallowing disorders of the American Academy of Otolaryngology-Head and Neck Surgery. Otolaryngol Head Neck Surg 2002; 127: 32-5.
7. Ford CN. Evaluation and management of laryngopharyngeal reflux. JAMA 2005; 294: 1534-40.
8. Reichel O, Keller J, Rasp G, Hagedorn H, Berghaus A. Efficacy of once-daily esomeprazole treatment in patients with laryngopharyngeal reflux evaluated by 24-hour pH monitoring. Otolaryngol Head Neck Surg 2007; 136: 205-10.
9. Reimer C, Bytzer P. Management of laryngopharyngeal reflux with proton pump inhibitors. Ther Clin Risk Manag 2008; 4: 225-33.
10. de Caestecker J. Prokinetics and reflux: a promise unfulfilled. Eur J Gastroenterol Hepatol 2002; 14: 5-7.
11. Kataria M, Traub M, Marsden CD. Extrapyramidal side-effects of metoclopramide. Lancet 1978; 2: 1254-5.
12. Champion MC, Hartnett M, Yen M. Domperidone, a new dopamine antagonist. CMAJ 1986; 135: 457-61.
13. Reddymasu SC, Soykan I, McCallum RW. Domperidone: review of pharmacology and clinical applications in gastroenterology. Am J Gastroenterol 2007; 102: 2036-45.
14. Pritchard DS, Baber N, Stephenson T. Should domperidone be used for the treatment of gastrooesophageal reflux in children? Systematic review of randomized controlled trials in children aged 1 month to 11 years old. Br J Clin Pharmacol 2005; 59: 725-9.
15. Ishoo E. P064: Role of Tegaserod in treatment of laryngopharyngeal reflux. Otolaryngol Head Neck Surg 2007; 137 (2 Suppl): P233-4.
16. Singhal SD, Dhawan P, Bhatt A, Pokhana R, Sharma D, Kumar G, et al. Evaluation of safety and efficacy of pantoprazole and domperidone combination in patients with gastroesophageal reflux disease. The Internet Journal of Gastroenterology [serial on the Internet] 2006 [cited 2010 Jun 16]; 4(2): [22 screens]. Available from: http://www.ispub.com/ostia/index.php?xmlFilePath=journals/ijge/vol4n2/reflux.xml
17. Smythe A, Bird NC, Troy GP, Ackroyd R, Johnson AG. Does the addition of a prokinetic to proton pump inhibitor therapy help reduce duodenogastro-oesophageal reflux in patients with Barrett's oesophagus? Eur J Gastroenterol Hepatol 2003; 15: 305-12.
18. van Rensburg CJ, Bardhan KD. No clinical benefit of adding cisapride to pantoprazole for treatment of gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol 2001; 13: 909-14.
19. Sharma B, Sharma M, Daga MK, Sachdev GK, Bondi E. Effect of omeprazole and domperidone on adult asthmatics with gastroesophageal reflux. World J Gastroenterol 2007; 13: 1706-10.
20. Kahrilas PJ, Quigley EM, Castell DO, Spechler SJ. The effects of tegaserod (HTF 919) on oesophageal acid exposure in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2000; 14: 1503-9.
21. Chung MK, Min JY, Oh JW, Jeong HS, Baek CH, Son YI. The Efficacy of 4-week short-therapy with proton pump inhibitor as an initial treatment regimen for the patients with laryngopharyngeal reflux. Korean J Otolaryngol Head Neck Surg 2005; 48: 796-800.
22. Lam PK, Ng ML, Cheung TK, Wong BY, Tan VP, Fong DY, et al. Rabeprazole is effective in treating laryngopharyngeal reflux in a randomized placebocontrolled trial. Clin Gastroenterol Hepatol 2010; 8: 770-6.
23. Reichel O, Dressel H, Wiederanders K, Issing WJ. Double-blind, placebo-controlled trial with esomeprazole for symptoms and signs associated with laryngopharyngeal reflux. Otolaryngol Head Neck Surg 2008; 139: 414-20.
24. Havas T, Huang S, Levy M, Abi-Hanna D, Preistly J, Truskett P, et al. Posterior pharyngolaryngitis: double-blind randomized placebo-controlled trial of proton pump inhibitor therapy. Aust J Otolaryngol 1999; 3: 243-8.
25. Noordzij JP, Khidr A, Evans BA, Desper E, Mittal RK, Reibel JF, et al. Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study. Laryngoscope 2001; 111: 2147-51.
26. Eherer AJ, Habermann W, Hammer HF, Kiesler K, Friedrich G, Krejs GJ. Effect of pantoprazole on the course of reflux-associated laryngitis: a placebocontrolled double-blind crossover study. Scand J Gastroenterol 2003; 38: 462-7.
27. El Serag HB, Lee P, Buchner A, Inadomi JM, Gavin M, McCarthy DM. Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial. Am J Gastroenterol 2001; 96: 979-83.
28. Steward DL, Wilson KM, Kelly DH, Patil MS, Schwartzbauer HR, Long JD, et al. Proton pump inhibitor therapy for chronic laryngo-pharyngitis: a randomized placebo-control trial. Otolaryngol Head Neck Surg 2004; 131: 342-50.
29. Vaezi MF, Richter JE, Stasney CR, Spiegel JR, Iannuzzi RA, Crawley JA, et al. Treatment of chronic posterior laryngitis with esomeprazole. Laryngoscope 2006; 116: 254-60.
30. Wo JM, Koopman J, Harrell SP, Parker K, Winstead W, Lentsch E. Double-blind, placebocontrolled trial with single-dose pantoprazole for laryngopharyngeal reflux. Am J Gastroenterol 2006; 101: 1972-8.
31. Belafsky PC, Postma GN, Koufman JA. Laryngopharyngeal reflux symptoms improve before changes in physical findings. Laryngoscope 2001; 111: 979-81.
32. DelGaudio JM, Waring JP. Empiric esomeprazole in the treatment of laryngopharyngeal reflux. Laryngoscope 2003; 113: 598-601.